Bio-tech Stocks – Not All Stem Cells Are Created EqualThe Market OracleBiotech companies are fiercely competing to create the newest and best miracle drugs using stem cell technologies. How can an investor spot the potentially victorious outliers amid the chaos of rival scientific claims? The failure rate of new product … and more …read more &nbs… Continue reading
Stem cells help repair traumatic brain injury by building a “biobridge”R & D MagazineUniv. of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a “biobridge” that links an uninjured … … Continue reading
Science CodexA group of Brigham and Women’s Hospital, and Harvard Stem Cell Institute researchers and collaborators at MIT and MGH have found a way to use stem cells as drug delivery vehicles. The researchers inserted modified strands of messenger RNA into … …read more &nbs… Continue reading
Nanowerk(Nanowerk News) A group of Brigham and Women’s Hospital, and Harvard Stem Cell Institute researchers, and collaborators at MIT and Massachusetts General Hospital have found a way to use stem cells as drug delivery vehicles. The researchers inserted … …read more &nbs… Continue reading
MS patients could benefit from new stem cell therapiesWebMD.Boots.com4th October 2013 – The potential for new methods of stem cell therapy to treat multiple sclerosis (MS) is discussed in a new report in the online edition of The Lancet. The paper, written by Professor Neil Scolding and colleagues from Frenchay Hospital … …read more &nbs… Continue reading
Not All Stem Cells Are Created Equal: Vernon BernardinoWall Street Sector SelectorBiotech companies are fiercely competing to create the newest and best miracle drugs using stem cell technologies. The Life Sciences Report: Vernon, how do you pick investor entry points for the life science firms that you cover for MLV & Co.? Vernon … and … Continue reading
Scientific American (blog)Paul Knoepfler Dr. Paul S. Knoepfler is an associate professor of Cell Biology and Human Anatomy at UC Davis School of Medicine, where his lab studies stem cell and cancer cell chromatin biology. He teaches histology to medical students and … …read more &nbs… Continue reading
Advancement in stem cell therapies show potential for multiple sclerosis careThe Information DailyA report outlining the progress of stem cell therapy – and new methods which could lead to an eventual cure for multiple sclerosis and other degenerative diseases – has been published today. More than 100,000 people in the UK are affected by multiple … Continue reading